Opioid addiction is a growing problem across the United States, and one that can be difficult to overcome without proper treatment and support. In an effort to help clients in recovery reduce cravings, a new form of the already FDA-approved drug buprenorphine has been developed. The drug is being manufactured as an implant called Probuphine and could provide up to six months of slow-release medication. California rehab center Chapters Capistrano has released a statement to the press regarding this development and what it could mean for addiction recovery.
“It’s encouraging to see progress being made on the addiction treatment front,” says Susie Shea, co-owner of the drug and alcohol rehab center in Orange County. “Many patients use some form of medication-assisted treatment to help curb cravings and reduce temptation, but options are limited and they have their pros and cons. An implant could change how clients receive and respond to treatment because it offers longer lasting results.
Probuphine has not yet been approved by the FDA, but has been recommended for approval by an FDA advisory panel. The implant would be placed just beneath the skin and slowly releases buprenorphine into the client’s system. Current formulations come in pill form or a dissolvable film that is placed under the tongue. These medications must be taken daily.
Some of the reported benefits of the implants include that clients don’t have to remember to take it every day and, because it’s not in pill form, it can’t be sold illegally. However, it wouldn’t be recommended for everyone trying to overcome opioid addictions. Ideal candidates would be those who are already doing well on a consistent, low-dose of buprenorphine, rather than those whose doses are still being adjusted or who require higher amounts. The implant could be used as a stepping stone to help clients work their way toward being medication-free according to Dr. David Pickar, a psychiatrist at the Johns Hopkins School of Medicine and a member of the advisory committee who voted to approve Probuphine.
“Only time will tell how effective Probuphine will be, and what clients it will be most effective for,” says Shea. “It is still very new and awaiting approval, so there isn’t a wealth of results to back it yet. But it shows that there is progress being made in the fight against addiction and providing clients with more options to support recovery.”
However, medication shouldn’t be a sole solution and clients should still participate in a luxury rehab treatment program to address the broad impact of addiction on their lives, notes Shea. Recovery requires a change in routine and thought processes, and comprehensive treatment can equip clients with these strategies. Medication can complement these efforts, though, and help with the transition to a substance-free lifestyle. Chapters Capistrano offers medically-supervised detox as well as holistic and evidence-based approaches to addiction treatment.
Chapters Capistrano is a luxury drug and alcohol treatment center located in the city of San Clemente in Orange County, California, with two beautiful ocean-view homes. Specializing in all types of substance abuse, Chapters offers flexible treatment programs that are designed to offer greater confidence in addiction recovery. With a thorough approach to detox, counseling and mental health, this center has delivered many success stories. In addition to offering alternative approaches to conventional recovery, Chapters is also recognized for providing guest comfort with exceptional accommodations, private rooms and cell and laptop allowance. Those searching to begin a new “Chapter” in addiction recovery are encouraged to contact the facility today.
Company Name: Chapters Capistrano
Contact Person: Marvin Kimble
Address:1525 Buena Vista
City: San Clemente
Country: United States